Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future.

Abstract : Sparked by the article from Lescuyer and colleagues in a recent issue, we aim here to further encourage interest in and discussion of clinically relevant biomarker research. We express our view on proteomics for biomarker discovery by addressing multiple relevant issues, including the inherent differences between biological fluids (and how these differences affect current analytical approaches) and experimental design to maximize the efficiency of moving from the bench to the bedside. Herein, we also include suggestions for definition of the term "biomarker", based on the use of a set of universal characterization/validation requirements, and illustrate several recent examples of successful transitions of benchtop proteomic studies work to clinical practice.
Type de document :
Article dans une revue
Journal of Proteome Research, American Chemical Society, 2007, 6 (12), pp.4549-55. 〈10.1021/pr070529w〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00409636
Contributeur : Marie Francoise Simon <>
Soumis le : mardi 11 août 2009 - 11:11:39
Dernière modification le : lundi 15 janvier 2018 - 16:26:01

Identifiants

Collections

Citation

David Good, Visith Thongboonkerd, Jan Novak, Jean-Loup Bascands, Joost Schanstra, et al.. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future.. Journal of Proteome Research, American Chemical Society, 2007, 6 (12), pp.4549-55. 〈10.1021/pr070529w〉. 〈inserm-00409636〉

Partager

Métriques

Consultations de la notice

484